METHOD FOR RECOMBINANT ERYTHROPOIETIN THERAPY OF ANAEMIA IN PREGNANT RECIPIENTS OF RENAL GRAFT Russian patent published in 2011 - IPC A61K33/26 A61K38/18 A61P7/06 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly, to obstetrics, and concerns therapy of anaemia in pregnant recipients of a renal graft. That is ensured by subcutaneous introduction of recombinant erythropoietin 2000 Units 3 times a week combined with intravenous introduction of iron preparations daily for 7 days in iron dosage 100 mg in 5 ml of the preparation to increase the Hb level by at least 5 g/l. The treatment proceeds with supporting therapy that involves administering recombinant erythropoietin 2000 Units subcutaneously once a week with underlying oral introduction of the iron preparations to achieve the Hb level at least 100 g/l throughout the second and third trimesters of pregnancy.

EFFECT: administration schedule of the preparations provides higher clinical effectiveness and reduced length of therapy of anaemia with reduced postoperative complications in the given group of patients.

2 ex